Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study V Panebianco, F Barchetti, A Sciarra, A Ciardi, EL Indino, R Papalia, ... Urologic oncology: seminars and original investigations 33 (1), 17. e1-17. e7, 2015 | 297 | 2015 |
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients G Minniti, V De Sanctis, R Muni, F Filippone, A Bozzao, M Valeriani, ... Journal of neuro-oncology 88, 97-103, 2008 | 262 | 2008 |
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers C Marchetti, F De Felice, I Palaia, G Perniola, A Musella, D Musio, L Muzii, ... BMC women's health 14, 1-6, 2014 | 229 | 2014 |
Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance CN De Cecco, B Ganeshan, M Ciolina, M Rengo, FG Meinel, D Musio, ... Investigative radiology 50 (4), 239-245, 2015 | 211 | 2015 |
The role of radiation therapy in bone metastases management F De Felice, A Piccioli, D Musio, V Tombolini Oncotarget 8 (15), 25691, 2017 | 187 | 2017 |
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging V Panebianco, F Barchetti, A Sciarra, D Musio, V Forte, V Gentile, ... European radiology 23, 1745-1752, 2013 | 164 | 2013 |
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation GL Gravina, C Festuccia, F Marampon, VM Popov, RG Pestell, BM Zani, ... Molecular cancer 9, 1-16, 2010 | 163 | 2010 |
Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis F De Felice, C Marchetti, A Musella, I Palaia, G Perniola, D Musio, L Muzii, ... Annals of surgical oncology 22, 2876-2880, 2015 | 107 | 2015 |
Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central … S Scoccianti, SM Magrini, U Ricardi, B Detti, M Buglione, G Sotti, ... Neurosurgery 67 (2), 446-458, 2010 | 101 | 2010 |
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population C Ciccarelli, F Vulcano, L Milazzo, GL Gravina, F Marampon, G Macioce, ... Molecular cancer 15, 1-15, 2016 | 99 | 2016 |
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals F Marampon, GL Gravina, A Di Rocco, P Bonfili, M Di Staso, C Fardella, ... Molecular cancer therapeutics 10 (1), 159-168, 2011 | 99 | 2011 |
A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases M Di Staso, L Zugaro, GL Gravina, P Bonfili, F Marampon, L Di Nicola, ... European radiology 21, 2004-2010, 2011 | 98 | 2011 |
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis C Marchetti, F De Felice, S Boccia, C Sassu, V Di Donato, G Perniola, ... Critical reviews in oncology/hematology 132, 111-115, 2018 | 97 | 2018 |
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells F Marampon, F Megiorni, S Camero, C Crescioli, HP McDowell, R Sferra, ... Cancer letters 397, 1-11, 2017 | 93 | 2017 |
Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients … CN De Cecco, M Ciolina, D Caruso, M Rengo, B Ganeshan, FG Meinel, ... Abdominal Radiology 41, 1728-1735, 2016 | 91 | 2016 |
Radiation effects on male fertility F De Felice, C Marchetti, F Marampon, G Cascialli, L Muzii, V Tombolini Andrology 7 (1), 2-7, 2019 | 90 | 2019 |
Immunotherapy of ovarian cancer: the role of checkpoint inhibitors F De Felice, C Marchetti, I Palaia, D Musio, L Muzii, V Tombolini, ... Journal of immunology research 2015 (1), 191832, 2015 | 85 | 2015 |
The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care F De Felice, A Polimeni, V Tombolini Radiotherapy and Oncology 147, 84-85, 2020 | 78 | 2020 |
Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review F De Felice, A Polimeni, V Valentini, O Brugnoletti, A Cassoni, A Greco, ... Neoplasia 20 (3), 227-232, 2018 | 75 | 2018 |
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage G Pannone, A Santoro, A Feola, P Bufo, P Papagerakis, L Lo Muzio, ... Current Cancer Drug Targets 14 (2), 115-127, 2014 | 72 | 2014 |